TREA

90282216 - AMPHIVENA RESTORE

Follow

Information

  • Trademark
  • 90282216
  • Serial Number
    90282216
  • Filing Date
    October 27, 2020
    4 years ago
  • Transaction Date
    September 26, 2022
    2 years ago
  • Status Date
    February 14, 2022
    2 years ago
  • Published for Opposition Date
    May 18, 2021
    3 years ago
  • Location Date
    July 13, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SEGAL, MOLLY DANIELA
  • Attorney Name
    Lisa Greenwald-Swire
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AMPHIVENA RESTORE
Case File Statements
  • GS0421: Laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells
Case File Event Statements
  • 2/14/2022 - 2 years ago
    17 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 2/14/2022 - 2 years ago
    16 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/13/2021 - 3 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/18/2021 - 3 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/18/2021 - 3 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/28/2021 - 3 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/12/2021 - 3 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/12/2021 - 3 years ago
    10 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/12/2021 - 3 years ago
    9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/12/2021 - 3 years ago
    8 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/12/2021 - 3 years ago
    7 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/8/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/8/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/8/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/18/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/30/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP